{Reference Type}: Letter
{Title}: Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists".
{Author}: Hong LT;Downes KJ;FakhriRavari A;Abdul-Mutakabbir JC;Kuti JL;Jorgensen S;Young DC;Alshaer MH;Bassetti M;Bonomo RA;Gilchrist M;Jang SM;Lodise T;Roberts JA;Tängdén T;Zuppa A;Scheetz MH;
{Journal}: Pharmacotherapy
{Volume}: 44
{Issue}: 2
{Year}: 2024 Feb
{Factor}: 6.251
{DOI}: 10.1002/phar.2907